The curated database of hedge funds that publish investor letters. Research by geography, strategy, and schools of thought.
| # | Fund | Strategy | Style | Geography | AUM | Latest Letter |
|---|---|---|---|---|---|---|
As of Oct 19, 2026
During the third quarter of 2026, the American Century Small Cap Value Fund's Investor Class returned -6.42% net of fees (-6.27% net of fees for the I Class), lagging its benchmark, the Russell 2000 Value Index, which returned -4.91%. Over the one-year trailing period, the Investor Class posted a gain of 11.12% net of fees. Performance detracted primarily from stock selection in the materials sector, where execution issues impacted construction materials holdings, and an underweight posture in healthcare as biotechnology and medical equipment constituents advanced strongly. The macroeconomic landscape was characterized by escalating geopolitical tension surrounding the conflict in Iran, resilient oil prices, and persistent inflation pressures that prompted a Federal Reserve benchmark interest rate increase in September. These tighter monetary dynamics pressured small-cap equities relative to large caps, though value factors outperformed growth across capitalizations. In response, the fund maintained disciplined overweights in industrials and energy, reduced banking exposure to underweight while increasing capital markets, and preserved a zero allocation to utilities. Portfolio turnover reflected opportunistic capital reallocation, including initiating new long positions in Morningstar for its subscription analytics and ADI Global Distribution for installer network scale. The fund completed full exits in MarineMax and Accelerant Holdings after announced buyout acquisitions largely realized upside potential. Significant relative contributors included Accelerant Holdings, NIQ Global Intelligence, and Crescent Energy, while detractors were led by Cardinal Infrastructure Group, Entravision Communications, and Bath & Body Works.
Long-term capital growth and income generated through disciplined individual stock selection in small-cap companies whose market valuations fail to reflect their underlying quality and normalized earnings power.
The fund expects to remain materially underweight in healthcare due to poor cash generation across industry groups and intends to seek risk/reward upside in cyclical market corners over speculative AI utilities.
Moderate Conviction Bullish
Market Conviction
Growth Outlook
Risk Appetite
Capital Deployment
Forward Guidance
Language Signal
Perceived Risk
Opportunity Density
Time Horizon
Top Conviction Themes
Key Catalysts
Every insight in this database connects to the original source. Read the actual thesis, see the actual concerns, and make your own call.
Buyside Digest has no business relationship, partnership, agency, sponsorship, endorsement, or affiliation with American Century Small Cap Value Fund or any other manager whose content appears on the Service, except where expressly stated. We do not receive Manager Content directly from managers in most cases; content is collected from publicly available sources. Managers have not necessarily reviewed, approved, authorized, or endorsed our display of their content, our editorial commentary, our metadata extraction, or our classifications. Use of a manager’s name is for accurate attribution and identification purposes only, under principles of nominative fair use.
Buyside Digest does not independently verify the regulatory status, registrations, licensing, qualifications, credentials, or professional standing of managers whose content appears on the Service. We do not represent that managers are properly registered with applicable regulatory bodies, that their content complies with applicable securities laws, or that their performance representations are accurate. Inclusion of a manager in our database is based on the publicly available nature of their content, not on our verification of their regulatory status or content compliance. Users are responsible for conducting their own due diligence on any manager.
Performance data, returns, assets under management (“AUM”), and similar figures displayed on this page are sourced from publicly available manager communications (including investor letters), public filings, or other third-party sources. Buyside Digest does not independently verify performance figures, calculate returns, or audit manager-reported data. Such figures: May be selectively reported by the manager; May use non-standard calculation methodologies; May not reflect fees, expenses, taxes, or other costs; May be inconsistent across reporting periods; May be outdated. Past performance is not indicative of future results. Performance figures should not be relied upon for investment decisions without independent verification. Users should request audited performance data directly from the manager and conduct their own due diligence.